Brief: Radiopharm Theranostics Says FDA Accepted Amended IND For Production And Distribution Of 68Ga-Trivehexin
17/10/2023 02:07
Oct 17 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* FDA ACCEPTED AMENDED IND FOR PRODUCTION AND DISTRIBUTION
OF
68GA-TRIVEHEXIN IN NEW YORK CITY
Source text for Eikon: ID:nASXbH8494
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%